EUROPE / INTERNATIONAL

EUROPE / INTERNATIONAL

As a leading biocluster in Europe, Genopole welcomes visiting delegations from the world-over every year. Although visits were obviously less numerous in 2020, exchanges continued throughout the year at a distance. The biocluster’s international visibility actions were fruitful, particularly in Europe. The Genopole-coordinated project GEN.ERA for the strategic computational genomics sector was chosen by the European Commission and the EU|BIC certification earned by the biocluster opens doors to a European network of 130 business centers.

COMPANIES

DRAWING A ROADMAP FOR EUROPE

The Europe & International team, in partnership with the European Union health innovation network EIT Health France, brought together a panorama of European funding offers in the health sector and presented good practices for responding efficaciously to European calls for proposals.

These calls are a useful doorway for businesses and laboratories seeking to work side-by-side with teams from other countries in a European dynamic. Such perspectives are made real not only by the coming framework program Horizon Europe and its European Innovation Council (EIC) but also by the EIT Health programs Incubate, Validate and Scale 2020.

COMPANIES

DESTINATION SINGAPORE WITH VISA4BIOTECH

For its accredited companies, Genopole held a Visa4Biotech meeting on Singapore and the opportunities there for the health and biotechnologies sectors.
The webinar, which emphasized intellectual and industry property, was organized with the French Chamber of Commerce in Singapore (FCCS), the Embassies of France in Singapore and Singapore in France, The Singapore Economic Development Board (EDB), the National Institute for Intellectual Property (INPI) and the DS Avocats law firm. Gourmey, a Genopole-accredited company, CellProthéra, an affiliate of which is implanted in Singapore, and Ipsen, an international biopharmaceuticals group with a presence in Singapore, shared their real-world experiences with doing business in that country.

visuel

TOWARD A COMMON EUROPEAN HEALTH DATA SPACE

Along with several other bioclusters, Genopole signed the ScanBalt Declaration calling for the creation of a common space for health data in Europe. As emphasized by Anne Jouvenceau, Deputy Director of Genopole:

“The question of a European space for health data is capital for the heart of Genopole’s activities, for computational genomics, bioproduction, innovative therapies and precision medicine. The more we give and share a large amount of data (genomic sequences, microscopic observations, medical CT or MRI images, etc.) the more our laboratories and businesses will be able to work rapidly and efficiently.”